- Home
- NLSP vs TRIB Comparison
NLSP vs TRIB Comparison
Compare NLSP & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NLSP
- TRIB
- Stock Information
- Founded
- NLSP 2015
- TRIB 1992
- Country
- NLSP Switzerland
- TRIB Ireland
- Employees
- NLSP N/A
- TRIB N/A
- Industry
- NLSP Biotechnology: Pharmaceutical Preparations
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- NLSP Health Care
- TRIB Health Care
- Exchange
- NLSP Nasdaq
- TRIB Nasdaq
- Market Cap
- NLSP 12.4M
- TRIB 14.0M
- IPO Year
- NLSP 2021
- TRIB N/A
- Fundamental
- Price
- NLSP $1.95
- TRIB $0.84
- Analyst Decision
- NLSP
- TRIB
- Analyst Count
- NLSP 0
- TRIB 0
- Target Price
- NLSP N/A
- TRIB N/A
- AVG Volume (30 Days)
- NLSP 171.1K
- TRIB 194.4K
- Earning Date
- NLSP 08-12-2025
- TRIB 08-13-2025
- Dividend Yield
- NLSP N/A
- TRIB N/A
- EPS Growth
- NLSP N/A
- TRIB N/A
- EPS
- NLSP N/A
- TRIB N/A
- Revenue
- NLSP N/A
- TRIB $61,555,000.00
- Revenue This Year
- NLSP N/A
- TRIB $13.51
- Revenue Next Year
- NLSP N/A
- TRIB $13.14
- P/E Ratio
- NLSP N/A
- TRIB N/A
- Revenue Growth
- NLSP N/A
- TRIB 8.31
- 52 Week Low
- NLSP $1.30
- TRIB $0.48
- 52 Week High
- NLSP $8.35
- TRIB $3.39
- Technical
- Relative Strength Index (RSI)
- NLSP 37.66
- TRIB 64.65
- Support Level
- NLSP $1.71
- TRIB $0.66
- Resistance Level
- NLSP $2.00
- TRIB $0.91
- Average True Range (ATR)
- NLSP 0.15
- TRIB 0.05
- MACD
- NLSP -0.03
- TRIB 0.02
- Stochastic Oscillator
- NLSP 21.67
- TRIB 77.78
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.